ATE297987T1 - Bedingte immortalisierung von zellen - Google Patents
Bedingte immortalisierung von zellenInfo
- Publication number
- ATE297987T1 ATE297987T1 AT00960846T AT00960846T ATE297987T1 AT E297987 T1 ATE297987 T1 AT E297987T1 AT 00960846 T AT00960846 T AT 00960846T AT 00960846 T AT00960846 T AT 00960846T AT E297987 T1 ATE297987 T1 AT E297987T1
- Authority
- AT
- Austria
- Prior art keywords
- cells
- conditional immortalization
- recombinant
- conditionally
- therapy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1241—Nucleotidyltransferases (2.7.7)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/82—Translation products from oncogenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/027—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a retrovirus
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99307405 | 1999-09-17 | ||
US09/663,537 US6399384B1 (en) | 1999-09-17 | 2000-09-15 | Conditional immortalization of cells |
PCT/GB2000/003588 WO2001021790A1 (en) | 1999-09-17 | 2000-09-18 | Conditional immortalisation of cells |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE297987T1 true ATE297987T1 (de) | 2005-07-15 |
Family
ID=26153574
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT00960846T ATE297987T1 (de) | 1999-09-17 | 2000-09-18 | Bedingte immortalisierung von zellen |
Country Status (11)
Country | Link |
---|---|
US (1) | US6399384B1 (de) |
EP (1) | EP1212420B1 (de) |
JP (1) | JP2003510046A (de) |
CN (1) | CN1373804A (de) |
AT (1) | ATE297987T1 (de) |
AU (1) | AU757816B2 (de) |
CA (1) | CA2383253A1 (de) |
DE (1) | DE60020855T2 (de) |
ES (1) | ES2241652T3 (de) |
IL (1) | IL148008A0 (de) |
WO (1) | WO2001021790A1 (de) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9518606D0 (en) * | 1995-09-12 | 1995-11-15 | Inst Of Psychiatry | Neural transplantation |
GB9907243D0 (en) * | 1999-03-29 | 1999-05-26 | Reneuron Ltd | Therapy |
GB0005856D0 (en) * | 2000-03-10 | 2000-05-03 | Reneuron Ltd | Genetic constructs |
DE10019195B4 (de) * | 2000-04-17 | 2006-03-09 | Heart Biosystems Gmbh | Reversible Immortalisierung |
US20040170955A1 (en) * | 2000-09-08 | 2004-09-02 | Wadih Arap | Human and mouse targeting peptides identified by phage display |
US7452964B2 (en) | 2001-09-07 | 2008-11-18 | Board Of Regents, The University Of Texas System | Compositions and methods of use of targeting peptides against placenta and adipose tissues |
US7420030B2 (en) | 2000-09-08 | 2008-09-02 | The Board Of Regents Of The University Of Texas System | Aminopeptidase A (APA) targeting peptides for the treatment of cancer |
US20050074747A1 (en) * | 2000-09-08 | 2005-04-07 | Wadih Arap | Biopanning and rapid analysis of selective interactive ligands (brasil) |
EP1207196A1 (de) * | 2000-10-27 | 2002-05-22 | Societe Des Produits Nestle S.A. | Immortalisierte pre-osteoblasten und verfahren zur deren herstellung |
EP1418932A4 (de) * | 2001-07-18 | 2006-03-15 | Univ Texas | Antiangiogener zustand bei mäusen und menschen mit retinaler photorezeptor-degeneration |
US8507445B2 (en) * | 2001-09-07 | 2013-08-13 | Board Of Regents, The University Of Texas System | Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer |
US7671010B2 (en) * | 2002-08-30 | 2010-03-02 | The Board Of Regents Of The University Of Texas System | Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer |
US20040048243A1 (en) * | 2001-09-07 | 2004-03-11 | Wadih Arap | Methods and compositions for in vitro targeting |
GB0125773D0 (en) * | 2001-10-26 | 2001-12-19 | Reneuron Ltd | Constructs |
JPWO2003038076A1 (ja) * | 2001-10-31 | 2005-02-24 | 株式会社レノメディクス研究所 | 不死化間葉系細胞及びその利用 |
DE60334533D1 (de) * | 2002-03-15 | 2010-11-25 | Univ Duke | Gewebe-engineering |
AU2004231094A1 (en) * | 2003-04-14 | 2004-10-28 | Board Of Regents, The University Of Texas System | Methods for ex vivo hybridoma-free production of polyclonal and monoclonal antibodies and generation of immortalized cell populations |
AU2004272340B2 (en) * | 2003-09-12 | 2008-01-03 | Dana Farber Cancer Institute | Immortalisation of mammalian cells and therapeutic applications of said cells |
US20050193432A1 (en) * | 2003-11-18 | 2005-09-01 | Whitehead Institute For Biomedical Research | Xenograft model of functional normal and malignant human breast tissues in rodents and methods thereof |
DK1645626T3 (da) * | 2004-09-30 | 2008-01-21 | Reneuron Ltd | Cellelinie |
US20090298095A1 (en) * | 2005-04-15 | 2009-12-03 | The John Hopkins University | Immortalization of cells including neuronal cells |
NZ569816A (en) * | 2005-12-16 | 2011-10-28 | Ribovax Biotechnologies Sa | Methods for obtaining immortalized antibody secreting cells |
GB0822246D0 (en) | 2008-12-05 | 2009-01-14 | Reneuron Ltd | Composition |
GB0902034D0 (en) | 2009-02-06 | 2009-03-11 | Reneuron Ltd | Method |
EP2380905A1 (de) | 2010-04-19 | 2011-10-26 | Thrombotargets Europe, S.L. | Phospholipidangereicherte Vesikel mit Gewebefaktor mit blutstillenden Aktivitäten sowie Verwendungen davon |
CN105176913A (zh) * | 2015-09-23 | 2015-12-23 | 扬州大学 | 一种奶牛乳腺上皮细胞永生化方法 |
JP2022513490A (ja) * | 2018-12-16 | 2022-02-08 | フィジーン、エルエルシー | 遺伝子編集線維芽細胞の治療的使用 |
GB202005494D0 (en) | 2020-04-15 | 2020-05-27 | Reneuron Ltd | Induced pluripotent cell comprising a contollable transgene for conditional immortalisation |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5270191A (en) * | 1988-04-12 | 1993-12-14 | Massachusetts Institute Of Technology | Method for manipulation of the cell types of eukaryotes |
US5766948A (en) | 1993-01-06 | 1998-06-16 | The Regents Of The University Of California | Method for production of neuroblasts |
EP0799315A2 (de) | 1994-12-19 | 1997-10-08 | Cold Spring Harbor Laboratory | Telomerase protein-komponente |
GB9518606D0 (en) | 1995-09-12 | 1995-11-15 | Inst Of Psychiatry | Neural transplantation |
DE69739497D1 (de) * | 1996-10-01 | 2009-08-27 | Geron Corp | Menschlische Telomerase katalytische Untereinheit |
WO1998037181A2 (en) | 1997-02-20 | 1998-08-27 | Whitehead Institute For Biomedical Research | Telomerase catalytic subunit gene and encoded protein |
-
2000
- 2000-09-15 US US09/663,537 patent/US6399384B1/en not_active Expired - Fee Related
- 2000-09-18 AU AU73015/00A patent/AU757816B2/en not_active Ceased
- 2000-09-18 JP JP2001525348A patent/JP2003510046A/ja active Pending
- 2000-09-18 AT AT00960846T patent/ATE297987T1/de not_active IP Right Cessation
- 2000-09-18 CA CA002383253A patent/CA2383253A1/en not_active Abandoned
- 2000-09-18 IL IL14800800A patent/IL148008A0/xx unknown
- 2000-09-18 EP EP00960846A patent/EP1212420B1/de not_active Expired - Lifetime
- 2000-09-18 DE DE60020855T patent/DE60020855T2/de not_active Expired - Lifetime
- 2000-09-18 ES ES00960846T patent/ES2241652T3/es not_active Expired - Lifetime
- 2000-09-18 WO PCT/GB2000/003588 patent/WO2001021790A1/en active IP Right Grant
- 2000-09-18 CN CN00812878A patent/CN1373804A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
CA2383253A1 (en) | 2001-03-29 |
AU7301500A (en) | 2001-04-24 |
JP2003510046A (ja) | 2003-03-18 |
EP1212420B1 (de) | 2005-06-15 |
DE60020855D1 (de) | 2005-07-21 |
US6399384B1 (en) | 2002-06-04 |
CN1373804A (zh) | 2002-10-09 |
ES2241652T3 (es) | 2005-11-01 |
IL148008A0 (en) | 2002-09-12 |
AU757816B2 (en) | 2003-03-06 |
DE60020855T2 (de) | 2006-05-04 |
WO2001021790A1 (en) | 2001-03-29 |
EP1212420A1 (de) | 2002-06-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE297987T1 (de) | Bedingte immortalisierung von zellen | |
DK1210411T3 (da) | Sammensætninger og fremgangsmåder til forbedret celledyrkning | |
NO20025402L (no) | Modifiserte ES-celler og ES-cellespesifikke gener | |
ATE549395T1 (de) | Medium und kultur von embryonalen stammzellen | |
IL148512A0 (en) | Methods for making recombinant proteins using apoptosis inhibitors | |
DK1474507T3 (da) | Fremgangsmåder og materialer til produktion af organiske produkter i celler af Candida arter | |
ATE342275T1 (de) | Vorübergehend-immortalisierte zellen zur verwendung in gentherapie | |
MXPA03007829A (es) | Catodos de pila de combustible novedosos y sus pilas de combustible. | |
ATE391175T1 (de) | Multidrug resistenz gen | |
DE602005023181D1 (de) | Lentivirusvektoren und deren verwendung | |
DK1137808T3 (da) | Fremgangsmåde til fremstilling af rekombinante celler | |
DK1032672T3 (da) | DNA19355-polypeptid, en tumornekrosefaktor-homolog | |
ATE326537T1 (de) | Schnell erzeugung von stabilen säugertier- zellinien mit gewinnung eines hohen gehalts von recombinanten proteine | |
DE60039677D1 (de) | Akt-3 nukleinsäure, polypeptide und deren verwendung | |
MXPA04001720A (es) | Acido nucleicos bv8 y polipeptidos con actividad mitogenica. | |
ATE321843T1 (de) | Zellen, kulturverfahren, und ihre verwendung in autologer transplantationstherapie | |
DE69903559T2 (de) | Verwendung von neuen zelltod inducierenden mitteln im synergismus mit interferon | |
FR2716205B1 (fr) | Récepteur galanine, acides nucléiques, cellules transformées et utilisations. | |
DE69515652D1 (de) | Verwendung von dna oligomeren zur hemmung von hiv durch reduktion ribosomaler leserasterverschichtung | |
AR020208A1 (es) | Construcciones de adn | |
DE69737597D1 (de) | Vektoren zur inhibierung von viralem und tumorwachstum | |
DK0994955T3 (da) | Öget produktion af secernerede proteiner med rekombinante gærceller | |
ATE355385T1 (de) | Herstellung von rekombinanten adenoviren und von adenovirus-genbanken | |
WO2000053759A8 (en) | Expression of human alpha-fetoprotein in mammalian cells | |
MY136860A (en) | Glutamine-auxothrophic human cells capable of producing proteins and capable of growing in a glutamine-free medium |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1212420 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |